Jürgen Pannek, MD | Authors


Prostate-Specific Antigen: What’s New in 1997

September 01, 1997

When used alone, prostate-specific antigen (PSA) is not sufficiently sensitive or specific to consider it an ideal tool for the early detection or staging of prostate cancer. To optimize the use of PSA, the concepts of PSA velocity,